Granahan Investment Management - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2018$255,000
-12.7%
2,5500.0%0.02%
+12.5%
Q3 2018$292,000
+27.5%
2,5500.0%0.02%
+14.3%
Q2 2018$229,0002,5500.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,100,140$110,069,0003.44%
Nitorum Capital, L.P. 246,248$24,637,0002.52%
Diag Capital Management, LP 21,220$2,123,0002.43%
Bridge City Capital, LLC 31,902$3,192,0002.08%
Lisanti Capital Growth, LLC 46,765$4,679,0001.89%
Arabesque Asset Management Ltd 17,400$1,741,0001.71%
PICTON MAHONEY ASSET MANAGEMENT 163,651$16,371,0001.46%
Dorsey Wright & Associates 43,003$4,302,0001.29%
AMERICAN CAPITAL MANAGEMENT INC 228,000$22,811,0001.22%
MOODY ALDRICH PARTNERS LLC 29,475$2,949,0000.97%
View complete list of HAEMONETICS CORP shareholders